Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR3C1 | P04150 | 1/20 | 0.36 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.35 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.35 |
| ▸ | IDO1 | P14902 | 4/20 | 0.35 |
| ▸ | AGXT | P21549 | 2/20 | 0.35 |
| ▸ | P2RX7 | Q99572 | 2/20 | 0.34 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
| ▸ | HTR2A | P28223 | 1/20 | 0.33 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.33 |
| ▸ | HRH1 | P35367 | 1/20 | 0.33 |
| ▸ | HTR2B | P41595 | 1/20 | 0.33 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.33 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | RIPK1 | Q13546 | 2/20 | 0.32 |
| ▸ | DPP4 | P27487 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28981934 | 0.81 | PKM (0.37) | NR3C1IDO1AGXTP2RX7PKM | |
| SCHEMBL564877 | 0.81 | IDO1 (0.50) | SLC6A2TAAR1IDO1AGXTHTR2A | |
| SCHEMBL564873 | 0.79 | SLC6A2 (0.36) | NR3C1SLC6A2TAAR1IDO1AGXT | |
| SCHEMBL31490495 | 0.79 | IDO1 (0.38) | NR3C1IDO1AGXTP2RX7PKM | |
| SCHEMBL564609 | 0.78 | NPC1 (0.43) | NR3C1SLC6A2P2RX7HTR2ASLC6A4 | |
| SCHEMBL30005666 | 0.74 | PKM (0.42) | IDO1AGXTP2RX7PKMKMT2A | |
| SCHEMBL3711398 | 0.74 | PKM (0.42) | IDO1AGXTP2RX7PKMKMT2A | |
| SCHEMBL3910128 | 0.74 | MPO (0.44) | TAAR1IDO1AGXTP2RX7PKM | |
| Hydrochloric Acid SCHEMBL856646 | 0.72 | MPO (0.43) | TAAR1IDO1AGXTP2RX7PKM | |
| SCHEMBL15638695 | 0.72 | TAAR1 (0.50) | NR3C1SLC6A2TAAR1IDO1HTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260091048-A1 | GIP RECEPTOR AGONIST COMPOUNDS | LILLY CO ELI (US) | 2026-04-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260091048-A1 | GIP RECEPTOR AGONIST COMPOUNDS | GIPR, GLP1R, GPR119 | NR3C1 115/4885SLC6A2 2245/4885TAAR1 157/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.